000 01340 a2200361 4500
005 20250511215024.0
264 0 _c19910222
008 199102s 0 0 eng d
022 _a0027-8874
024 7 _a10.1093/jnci/83.2.129
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKrigel, R L
245 0 0 _aHemorrhagic gastritis as a new dose-limiting toxicity of recombinant tumor necrosis factor.
_h[electronic resource]
260 _bJournal of the National Cancer Institute
_cJan 1991
300 _a129-31 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aEndothelium, Vascular
_xdrug effects
650 0 4 _aGastritis
_xchemically induced
650 0 4 _aGastrointestinal Hemorrhage
_xchemically induced
650 0 4 _aHumans
650 0 4 _aNeoplasms
_xtherapy
650 0 4 _aRecombinant Proteins
_xadministration & dosage
650 0 4 _aTumor Necrosis Factor-alpha
_xadministration & dosage
700 1 _aPadavic-Shaller, K A
700 1 _aRudolph, A A
700 1 _aYoung, J D
700 1 _aWeiner, L M
700 1 _aKonrad, M
700 1 _aComis, R L
773 0 _tJournal of the National Cancer Institute
_gvol. 83
_gno. 2
_gp. 129-31
856 4 0 _uhttps://doi.org/10.1093/jnci/83.2.129
_zAvailable from publisher's website
999 _c1994872
_d1994872